Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

Vanda Pharmaceuticals sees strong growth with Fanapt for bipolar I disorder, projects 2025 revenue up 6%-26%, and targets $1B by 2030.

Sun Pharmaceutical Industries reported a 15% rise in net profit for the December quarter, driven by strong global sales. The company's revenue reached Rs 13,675 crore. An interim dividend of Rs 10.5 ...

HYDERABAD/BENGALURU (Reuters) -Sun Pharmaceutical, India’s largest drugmaker by revenue, reported a bigger-than-expected quarterly profit on Friday, aided by strong sales in the domestic market. The ...

Shares of Sun Pharma Ltd., India's largest drugmaker gained as much as 1.3% after declining as much as 2% when it reported its December quarter results. The stock gained despite its US formulation ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

Swiss pharmaceutical giant Novartis on Friday reported better-than-expected sales in the fourth quarter ... "We actually have tremendous replacement power," he said, referring to drug makers ...

On Friday, when AbbVie reported its quarterly earnings, the pharma giant jacked up its 2027 projected sales of Humira follow-ons Skyrizi and Rinvoq to a combined $31 billion. It is a $4 billion ...

Sales representatives are too familiar with ... to gather real-time insights on buying behaviors and follow structured templates for consistent execution. Co-founder & General Partner at JAL ...

Poxel eligible for royalties equaling 10% of all TWYMEEG ® net sales for 2024 and a one-time sales-based payment of JPY 500 million (EUR 3.1 million 3). Beyond 2024, Poxel expects to receive ...